Theranostec Inc.
Carmichael, CA
- UEI
- C1B4H9JHQ3J6
- CAGE
- 7QZG9
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5416 Braninburg Ct, Carmichael, CA 95608, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Theranostec Inc. is a corporate entity registered to receive federal contract and grant awards from the U.S. government. It specializes in developing transformable nano-theranostics for cancer treatment and imaging-guided interventions. Theranostec Inc. has received multiple project grants from the National Institutes of Health (NIH) National Cancer Institute to support its research and development efforts.
Through these federal grant awards, Theranostec Inc. has developed innovative nanoparticle-based drug delivery systems and imaging agents for targeted cancer therapy. One notable project involves sub-100 nm self-therapeutic nanoparticles as next-generation autophagy inhibitors for improving pancreatic ductal adenocarcinoma treatment. This $799,998 NIH grant aims to optimize the nanoparticle formulation for enhanced tumor penetration and support future large-scale production. Another significant award is a $2,899,788 NIH grant to translate transformable nano-theranostics (TNTs) into clinical trials for precision image-guided intervention of head and neck squamous cell carcinoma. This project involves synthesizing GMP-grade TNTs, conducting pharmacology and toxicology studies, and drafting an Investigational New Drug (IND) application for a phase I clinical trial. Theranostec Inc. has also received a $300,000 NIH grant for developing transformable nano-theranostics for imaging-guided interventions in head and neck squamous cell carcinoma.
Quick answers
Is Theranostec Inc. registered in SAM.gov?
Yes. Theranostec Inc.'s SAM.gov registration is active through January 6, 2027.
What is Theranostec Inc.'s most recent federal award?
Theranostec Inc.'s most recent federal grant award is Sub-100 NM and scalable self-therapeutic nanoparticles to target autophagy in pancreatic cancer - title: sub-100 NM and… (R43CA272110), from National Cancer Institute (NIH), on September 8, 2022.
On GovTribe
See Theranostec Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors